Australia's largest stock trading and investment forum Australia's #1 stock forum

BOT

Click for more information

2.94%

33.0¢ botanix pharmaceuticals ltd

While still not from BOT so therefore take it with a grain of...

First 285 Last

Share
Profile

Follow
Mikey74

1,391 Posts.

284

20/06/24

23:20

Post #: 74415784
Share

Originally posted by dachopper: ↑

Understood, you are quoting a hypothetical net sales figure that was used by BOT as a hypothetical. They never said it would be that, and it's not net profit so you can't use it to calculate PE. My point was it cannot possibly be net profit as Tax alone is bigger than the margin.

BOT did say the price would command a higher value than competitors which are $690 a month. So we have a definante gross sales at least starting in the 700's.

When calculating PE, it's based on overall company profit and that needs to take into account all costs ( not just sales cost)

Having said that now, we are miles away from sales so SP could do anything in the meantime. It will respond to market demand, that should be good while we await Q4.

Expand

While still not from BOT so therefore take it with a grain of salt, this is from the E&P report - Page 41

In the U.S., seven major plans cover approximately 80% of lives, making these engagements crucial. While the progress of these
negotiations remains somewhat opaque and reliant on optimistic company guidance, it is assumed that Sofdra will be reimbursed at a
level commensurate with a unit list price of approximately $750 per prescription, with a gross-to-net adjustment of around 30%.

Last edited by Mikey74: 20/06/24

BOT Price at posting: 33.5¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Week 27 Wrap: "Election year" is here as UK Labour win contrasts France; Trump wins immunity & annual report season hushes ASX

ITM

Fast-track assaying yields 182 g/t gold for iTech at new NT play

Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25

LLL

Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng

STN

Saturn’s stars have aligned for the gold explorer’s Apollo Project

There are more pages in this discussion • 217 more messages in this thread...

First 285 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 33.0¢		Change -0.010(2.94%)		Mkt cap ! $606.3M

Open	High	Low	Value	Volume
34.0¢	34.0¢	33.0¢	$556.1K	1.667M

Buyers (Bids)

No.	Vol.	Price($)
3	259203	33.0¢

Sellers (Offers)

Price($)	Vol.	No.
33.5¢	673181	9

View Market Depth

No.	Vol.	Price($)
3	259203	0.330
23	982902	0.325
21	1167250	0.320
14	976832	0.315
14	1031817	0.310

Price($)	Vol.	No.
0.335	673181	9
0.340	699659	11
0.345	382973	8
0.350	332050	10
0.355	133069	6

Last trade - 11.34am 08/07/2024 (20 minute delay)

BOT (ASX) Chart